Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo

International Journal of Cancer

Volumn 83, Issue 3, 1999, Pages 374-380

  Kuriyama, Shigeki ^a   Kikukawa, Masaji ^a   Masui, Kazuhiro ^a   Okuda, Hirotsugu ^a   Nakatani, Toshiya ^a   Akahane, Takemi ^a   Mitoro, Akira ^a   Tominaga, Kentaro ^a   Tsujinoue, Hirohisa ^a   Yoshiji, Hitoshi ^a   Okamoto, Shingo ^a   Fukui, Hiroshi ^a   Ikenaka, Kazuhiro ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS ENZYME; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FEMALE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0032848688     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991029)83:3<374::aid-ijc13>3.0.co;2-%23     Document Type: Article

References (21)

1. BARBA, D., HARDIN, J., SADELAIN, M. and GAGE, F.H., Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. nat. Acad. Sci. (Wash.), 91, 4348-4352 (1994).
2. CAO, G., KURIYAMA, S., CUI, L., NAGAO, S., PAN, X., TOYOKAWA, Y., ZHANG, X., NISHIWAKI, I. and QI, Z., Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. Cancer Gene Ther. (1999). (In press).
3. CAO, G., KURIYAMA, S., DU, P., SAKAMOTO, T., YANG, W., MASUI, K. and QI, Z., Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes. J. Gastroenterol. Hepatol., 11, 1053-1061 (1996).
4. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.L. and KLATZMANN, D., Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. nat. Acad. Sci. (Wash.), 90, 7024-7028 (1993).
5. COLOMBO, B.M., BENEDETTI, S., OTTOLENGHI, S., MORA, M., POLLO, B., POLI, G. and FINOCCHIARO, G., The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6, 763-772 (1995).
6. GAGANDEEP, S., BREW, R., GREEN, B., CHRISTMAS, S.E., KLATZMANN, D., POSTON, G.J. and KINSELLA, A.R., Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect." Cancer Gene Ther., 3, 83-88 (1996).
7. HALL, S.J., SANFORD, M.A., ATKINSON, G. and CHEN, S.-H., Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res., 58, 3221-3225 (1998).
8. HOLDER, J.W., ELMORE, E. and BARRETT, J.C., Gap junction function and cancer. Cancer Res., 53, 3475-3485 (1993).
9. ISHII-MORITA, H., AGBARIA, R., MULLEN, C.A., HIRANO, H., KOEPLIN, D.A., RAM, Z., OLDFIELD, E.H., JOHNS, D.G. and BLAESE, R.M., Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther., 4, 244-251 (1997).
10. KIANMANESH, A.R., PERRIN, H., PANIS, Y., FABRE, M., NAGY, H.J., HOUSSIN, D. and KLATZMANN, D.A., A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum. Gene Ther., 8, 1807-1814 (1997).
11. KURIYAMA, S., KIKUKAWA, M., MASUI, K., OKUDA, H., NAKATANI, T., SAKAMOTO, T., YOSHIJI, H., FUKUI, H., IKENAKA, K., MULLEN, C.A. and TSUJII, T., Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice. Int. J. Cancer, 81, 592-597 (1999).
12. KURIYAMA, S., NAKATANI, T., MASUI, K., SAKAMOTO, T., TOMINAGA, K., YOSHIKAWA, M., FUKUI, H., IKENAKA, K. and TSUJII, T., Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology, 22, 1838-1846 (1995).
13. KURIYAMA, S., SAKAMOTO, T., KIKUKAWA, M., NAKATANI, T., TOYOKAWA, Y., TSUJINOUE, H., IKENAKA, K., FUKUI, H. and TSUJII, T., Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment. Gene Ther., 5, 1299-1305 (1998).
14. KURIYAMA, S., SAKAMOTO, T., MASUI, K., NAKATANI, T., TOMINAGA, K., KIKUKAWA, M., YOSHIKAWA, M., IKENAKA, K., FUKUI, H. and TSUJII, T., Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma. Int. J. Cancer, 71, 470-475 (1997).
15. KURIYAMA, S., YOSHIKAWA, M., TOMINAGA, K., NAKATANI, T., SAKAMOTO, T., FUKUI, H., IKENAKA, K. and TSUJII, T., Gene therapy for the treatment of hepatoma by retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase. Int. Hepatol Comm., 1, 253-259 (1993).
16. MULLEN, C.A., ANDERSON, L., WOODS, K., NISHINO, M. and PETROPOULOS, D., Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses. Hum. Gene Ther., 9, 2019-2030 (1998).
17. PAILLARD F., Bystander effects in enzyme/prodrug gene therapy. Hum. Gene Ther., 8, 1733-1736 (1997).
18. ROGERS, R.P., GE, J.-Q., HOLLEY-GUTHRIE, E., HOGANSON, D.K., COMSTOCK, K.E., OLSEN, J.C. and KENNEY, S., Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. Hum. Gene Ther., 7, 2235-2245 (1996).
19. UCKERT, W., KAMMERTÖNS, T., HAACK, K., QIN, Z., GEBERT, J., SCHENDEL, D.J. and BLANKENSTEIN, T., Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum. Gene Ther., 9, 855-865 (1998).
20. VILE, R.G., CASTLEDEN, S., MARSHALL, J., CAMPLEJOHN, R., UPTON, C. and CHONG, H., Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Int. J. Cancer; 71, 267-274 (1997).
21. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H. and HART, I.R., Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54, 6228-6234 (1994).